TAMS is an association that is designed to provide education, awareness, advocacy, support and research for those living with a rare mast cell disorder (MCAS) called Mastocytosis. We are not for profit, operating by the efforts of volunteers who either suffer or care for someone with the condition.
Donate to TAMS and help raise money for research, education, support and advocacy.
BECOME A MEMBER
TAMS is a volunteer-run, membership association. TAMS members receive discounts for TAMS conferences and events, member e-newsletters, online and face-to-face support groups and more.
The TAMS committee advocates on behalf of TAMS Members to the medical communication and government.
The annual TAMS Conference has been running since 2012. Our Conferences feature many speakers and workshops on dealing with mastocytosis and MCAD and provide delegates with the opportunity to meet others in a relaxed and friendly environment.
Our upcoming 2019 TAMS Conference will be held 27-29 September in Canberra. Tickets are now on sale.
The Australasian Mastocytosis Society (TAMS) has been created as an advocacy, education and support body for those throughout Australasia who suffer from or care for those with Mastocytosis or Mast Cell Activation Syndrome (MCAS). TAMS has been established due to the overwhelming need for sufferers and their supporters to find a local voice and active support network.
TAMS is an independent ‘not for profit’ incorporated organisation with a committed and functional volunteer committee of individuals – all of whom are sufferers or carers – ensuring your needs will be met.
WHAT WE DO
PROVIDE A NETWORK
of support for patients living with mast cell disorders including Systemic Mastocytosis, Cutaneous Mastocytosis and Mast Cell Activation Syndrome (MCAS) and their carers.
to medical practitioners and specialists with knowledge of Mastocytosis and MCAS.
with associations to collectively gather research data, share resources and knowledge for greater understanding, treatment practices, medications and improved health outcomes.